Table 1.
Characteristics of the included studies.
| Study (year) | Country | Sample size | Gender | Mean age (years) | Pain duration (months) | Intervention | Exposure | Outcome measures | Follow-up points |
| Afzal et al (2022) [19] | Pakistan |
|
|
|
—c |
|
12 sessions; 3 times per week | VASd; ODIe | 4 weeks |
| Eccleston et al (2022) [50] | Finland |
|
|
|
|
|
30 sessions; 5 times per week; 15-60 minutes per session | NRSf; ODI; PROMISg 6b; TSKh; pain medications; EuroQoL-5D-5Li; adverse events; PGICj; Game Experience Questionnaire | 9 weeks, 5 months |
| Garcia et al (2021) [60] | United States |
|
|
|
|
|
56 sessions; 7 times per week; 2-16 minutes per session | DVPRSk; DVPRS-II; PSEQl-2; PGIC; PROMIS 6b and 6a; PCSm; CPAQ-8n | 8 weeks, 3 months, 6 months |
| Groenveld et al (2023) [61] | Netherlands |
|
|
|
|
|
60 sessions; 3 times per day; 10-30 minutes per session | SF-12o; VAS; PCS; HADSp; ODI; PCCLq; NEADLr; BPIs | 4 weeks, 4 months |
| Kim et al (2014) [20] | South Korea |
|
|
|
— |
|
12 sessions; 3 times per week; 30 minutes per session | VAS; pressure algometry; ODI; RMDQt; FABQu | 4 weeks |
| Kim et al (2020) [62] | South Korea |
|
|
|
|
|
16 sessions; 2 times per week; 46 minutes per session | NRS; ODI; RMDQ; FABQ | 4 weeks, 8 weeks, 6 months |
| Li et al (2021) [51] | China |
|
|
|
|
|
10 sessions; 5 times per week; 30 minutes per session | VAS; ODI; sEMGv | 2 weeks |
| Meinke et al (2022) [63] | Switzerland |
|
|
|
— |
|
9 sessions; 3 times per week; 20 minutes per session | NRS; TSK; RMDQ; WHOQOL-Brefw | 3 weeks |
| Monteiro-Junior et al (2015) [57] | Brazil |
|
|
|
— |
|
24 sessions; 3 times per week; 90 minutes per session | NRS; WBB; sit-to-stand test; POMSy | 8 weeks |
| Nambi et al (2020) [54] | Saudi Arabia |
|
|
|
|
|
20 sessions; 5 times per week; 30 minutes per session | VAS; player wellness; sprint performance; jump performance | 4 weeks, 8 weeks, 6 months |
| Nambi et al (2021) [55] | Saudi Arabia |
|
|
|
|
|
20 sessions; 5 times per week; 30 minutes per session | NRS; physical fitness index; sprint performance; jump performance | 4 weeks, 8 weeks, 6 months |
| Nambi et al (2021) [53] | Saudi Arabia |
|
|
|
|
|
20 sessions; 5 times per week; 30 minutes per session | VAS; TSK; blood serum level of stress hormones | 4 weeks, 6 months |
| Nambi et al (2021) [52] | Saudi Arabia |
|
|
|
|
|
20 sessions; 5 times per week; 30 minutes per session | VAS; TSK; blood serum level of stress hormones | 4 weeks, 6 months |
| Oh et al (2014) [56] | South Korea |
|
|
|
|
|
40 sessions; 5 times per week; 15-35 minutes per session | VAS; body composition; isokinetic trunk and hip extension or flexion and hip abduction or adduction | 8 weeks |
| Park et al (2013) [21] | South Korea |
|
— |
|
|
|
24 sessions; 3 times per week; 80 minutes per session | VAS; isometric lifting strength for back strength; 1-legged Stand Test for balance ability; RAND-36z; SF-36aa | 8 weeks |
| Park et al (2020) [58] | South Korea |
|
|
|
|
|
36 sessions; 3 times per week; 30 minutes per session | VAS; ODI; body composition; isokinetic trunk extension and flexion; spinal alignment | 12 weeks |
| Yalfani et al (2022) [22] | Japan |
|
|
|
|
|
24 sessions; 3 times per week; 30 minutes per session | VAS; SF-36; FRIab; BBSac | 2 weeks |
| Yilmaz Yelvar et al (2017) [64] | Iran |
|
|
|
|
|
10 sessions; 5 times per week | VAS; TSK; ODI; Nottingham Health Profile; TUGae; 6MWTaf; single-leg balance test | 2 weeks |
| Yoo et al (2014) [59] | South Korea |
|
|
|
|
|
24 sessions; 3 times per week; 20-50 minutes per session | VAS; body composition; isokinetic trunk strength | 8 weeks |
| Zadro et al (2019) [65] | Turkey |
|
|
|
|
|
24 sessions; 3 times per week; 60 minutes per session | NRS; TSK; PSEQ; 3-item questionnaire; Rapid Assessment of Physical Activity questionnaire; PSFSag; RMDQ; 16-item Falls Efficacy Scale-International Questionnaire | 8 weeks |
aExp: experimental group.
bCon: control group.
cNot available.
dVAS: Visual Analog Scale.
eODI: Oswestry Disability Index.
fNRS: Numerical Rating Scale.
gPROMIS: Patient-Reported Outcomes Measurement Information System.
hTSK: Tampa Scale of Kinesiophobia.
iEuroQoL-5D-5L: European Quality of Life 5-dimension, 5-level scale.
jPGIC: Patient’s Global Impression of Change.
kDVPRS: Defense and Veterans Pain Rating Scale.
lPSEQ: Pain Self-Efficacy Questionnaire.
mPCS: Pain Catastrophizing Scale.
nCPAQ-8: Chronic Pain Acceptance Questionnaire.
oSF-12: 12-item Short-Form Health Survey.
pHADS: Hospital Anxiety and Depression Scale.
qPCCL: Pain Coping and Cognition List.
rNEADL: Nottingham Extended Activities of Daily Living.
sBPI: Brief Pain Inventory.
tRMDQ: Roland Morris Disability Questionnaire.
uFABQ: Fear Avoidance Beliefs Questionnaire.
vsEMG: surface electromyography.
wWHOQOL-Brief: World Health Organization Quality of Life Questionnaire-short version.
xWBB: Wii Balance Board.
yPOMS: Profile of Mood States.
zRAND-36: RAND-36 Health Status Inventory.
aaSF-36: 36-item Short-Form Health Survey.
abFRI: Fall Risk Index.
acBBS: Biodex Balance System.
adTENS: transcutaneous electrical nerve stimulation.
aeTUG: Timed Up and Go Test.
af6MWT: 6-Minute Walk Test.
agPSFS: Patient-Specific Functional Scale.